Demographic changes in tuberculosis: High risk groups

Southern Medical Journal

Volumn 92, Issue 3, 1999, Pages 280-284

  Mehta, Jay B ^a   Roy, Thomas M ^b   Hughes, Shirley K ^b   Byrd Jr , Ryland P ^b   Harvill, Leo M ^b  

^a East Tennessee State University   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; PYRAZINAMIDE; QUINOLONE DERIVATIVE;

AGE; CONFERENCE PAPER; DEMOGRAPHY; DISEASE ASSOCIATION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREVALENCE; RACE; RISK FACTOR; SEX; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0032989651     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199903000-00004     Document Type: Conference Paper

References (25)

1. US Department of Health and Human Services: Tuberculosis Statistics in the US, 1990. Atlanta, Centers for Disease Control, 1996, pp 1-25
2. American Thoracic Society: Control of tuberculosis in the United States. Am Rev Respir Dis 1992; 146:1623-1633
3. Moore WL Jr: TB Control Program Annual Reports: 1990-1996. Nashville, Tennessee Department of Health, 1996, pp 1-25
4. HIV/AIDS in Tuberculosis Annual Reports: 1982-1985. Nashville, Tennessee Department of Health, 1991, pp 1-25
5. Roy TM, Mehta JB, Harvill LM: Extrapulmonary tuberculosis in Tennessee: lessons from the last decade. J Tenn Med Assoc 1996; 89:8-12
6. Centers for Disease Control: Tuberculosis control laws - United States, 1993: recommendations of the advisory council for the elimination of tuberculosis. MMWR 1993; 42:1-12
7. Braun MM, Byers RH, Heyward WL, et al: Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med 1990; 150:1913-1916
8. Selwyn PA, Hartel D, Lewis VA, et al: A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320:545-550
9. Mehta JB, Dutt AK, Harvill L, et al: Epidemiology of extrapulmonary tuberculosis a comparative analysis with pre-AIDS era. Chest 1991; 99:1134-1138
10. Gately KW: TB Control Program Annual Reports: 1990-1996. Nashville, Tennessee Department of Health, 1996, pp 1-25
11. Centers for Disease Control: Prevention and control of tuberculosis in facilities providing long-term care to the elderly: recommendations of the advisory council for elimination for tuberculosis. MMWR 1990; 39:7-20
12. Annas GJ: Control of tuberculosis - the law and the public's health. N Engl J Med 1993; 328:585-588
13. Gostin LO: Controlling the resurgent tuberculosis epidemic: a 50-state survey of TB statutes and proposals for reform. JAMA 1993; 269:255-261
14. Weis SE, Slevum PC, Blais FX, et al: The effect of DOT on the rate of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330:1179-1184
15. Iseman MD: Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329:784-791
16. Beck-Sagué C, Dooley SW, Hutton MD, et al: Outbreak of multidrug-resistant Mycobacterium tuberculosis infections in a hospital: transmission to patients with HIV infection and staff. JAMA 1992; 268:1280-1286
17. Alwood K, Keruly J, Moore-Rice K, et al: Effectiveness of supervised, intermittent therapy for tuberculosis in HIV infected patients. AIDS 1994; 8:1103-1108
18. Burman WJ, Cohn DL, Rietmeijer CA, et al: Short-term incarceration for the management of noncompliance with tuberculosis treatment. Chest 1997; 112:57-62
19. Morris JT, McAllister CK: Homeless individuals and drug-resistant tuberculosis in south Texas. Chest 1992; 102:802-804
20. Dutt AK, Stead WW: Treatment of extrapulmonary tuberculosis. Semin Respir Infect 1989; 4:225-231
21. Burman WJ, Dalton CB, Cohn DL, et al: A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis. Chest 1997; 112:63-70
22. Raviglione MC, Snider DE Jr, Kochi A: Global epidemiology of tuberculosis: mortality and morbidity of a worldwide epidemic. JAMA 1995; 273:220-226
23. Brudney K, Dobkin J: Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144:745-749
24. Centers for Disease Control: Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons -Florida and New York, 1988-1991. MMWR 1991; 40:585-591
25. Centers for Disease Control: The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the advisory council for the elimination of tuberculosis and the advisory council for the elimination of tuberculosis and the advisory committee on immunization practices. MMWR 1996; 45:1-18